Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
213.074955855
InChI
InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6?,7-/m0/s1
InChI Key
InChIKey=RXRGZNYSEHTMHC-MLWJPKLSSA-N
IUPAC Name
4-amino-1-[(2S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]-1,2-dihydropyrimidin-2-one
Traditional IUPAC Name
4-amino-1-[(2S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one
SMILES
NC1=NC(=O)N(C=C1)C1CO[C@H](CO)O1
pKa (strongest acidic)
13.85
pKa (Strongest Basic)
-0.49
Refractivity
48.73 m3·mol-1
Dược Lực Học :
Troxacitabine is a beta-L-nucleoside analog, which has shown preclinical antitumor activity in human xenograft tumor models and antileukemic response in patients with relapsed myeloid leukemia.
Cơ Chế Tác Dụng :
Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
Troxacitabine is activated by cellular kinases and incorporated into DNA, inhibiting its replication. In contrast to other cytosine nucleoside analogs, troxacitabine is resistant to inactivation by cytidine deaminase (CD).
Chỉ Định :
Investigated for use/treatment in leukemia (myeloid).